Education
About Us
Working with TipRanks
Follow Us
Wakamoto Pharmaceutical Co., Ltd. (JP:4512)
:4512
RESEARCH TOOLSreports
4512 Stock Chart & Stats
Day’s Range― - ―
52-Week Range¥209.00 - ¥377.00
Previous CloseN/A
Volume100.70K
Average Volume (3M)494.40K
Market Cap
¥10.69B
Enterprise Value¥8.42B
Total Cash (Recent Filing)¥3.56B
Total Debt (Recent Filing)¥100.00M
Price to Earnings (P/E)160.0
Beta0.29
Next Earnings
Nov 05, 2025EPS EstimateN/A
Last Dividend Ex-Date
Mar 28, 2025Dividend Yield0.97%
Share Statistics
EPS (TTM)-3.12
Shares Outstanding34,838,326
10 Day Avg. Volume142,990
30 Day Avg. Volume494,400
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
¥292.00Price Target Upside-5.19% Downside
Rating ConsensusHold
Number of Analyst Covering0
4512 FAQ
What was Wakamoto Pharmaceutical Co., Ltd.’s price range in the past 12 months?
Wakamoto Pharmaceutical Co., Ltd. lowest stock price was ¥209.00 and its highest was ¥377.00 in the past 12 months.
What is Wakamoto Pharmaceutical Co., Ltd.’s market cap?
Wakamoto Pharmaceutical Co., Ltd.’s market cap is ¥10.69B.
When is Wakamoto Pharmaceutical Co., Ltd.’s upcoming earnings report date?
Wakamoto Pharmaceutical Co., Ltd.’s upcoming earnings report date is Nov 05, 2025 which is in 65 days.
How were Wakamoto Pharmaceutical Co., Ltd.’s earnings last quarter?
Wakamoto Pharmaceutical Co., Ltd. released its earnings results on Aug 01, 2025. The company reported -¥3.12 earnings per share for the quarter, missing the consensus estimate of N/A by -¥3.12.
Is Wakamoto Pharmaceutical Co., Ltd. overvalued?
According to Wall Street analysts Wakamoto Pharmaceutical Co., Ltd.’s price is currently Overvalued.
Does Wakamoto Pharmaceutical Co., Ltd. pay dividends?
Wakamoto Pharmaceutical Co., Ltd. pays a Annually dividend of ¥3 which represents an annual dividend yield of 0.97%. See more information on Wakamoto Pharmaceutical Co., Ltd. dividends here
What is Wakamoto Pharmaceutical Co., Ltd.’s EPS estimate?
Wakamoto Pharmaceutical Co., Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Wakamoto Pharmaceutical Co., Ltd. have?
Wakamoto Pharmaceutical Co., Ltd. has 34,838,326 shares outstanding.
What happened to Wakamoto Pharmaceutical Co., Ltd.’s price movement after its last earnings report?
Wakamoto Pharmaceutical Co., Ltd. reported an EPS of -¥3.12 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Wakamoto Pharmaceutical Co., Ltd.?
Currently, no hedge funds are holding shares in JP:4512
Company Description
Wakamoto Pharmaceutical Co., Ltd.
Wakamoto Pharmaceutical Co., Ltd. is a Japanese pharmaceutical company engaged in the development, manufacture, and sale of pharmaceutical and healthcare products. The company operates primarily in the healthcare sector, offering a range of products that include over-the-counter medications, prescription drugs, and nutritional supplements. Wakamoto is particularly well-known for its gastrointestinal medications and health supplements that cater to a broad consumer base.
Technical Analysis
Morishita Jintan Co., Ltd.
―
Fuso Pharmaceutical Industries,Ltd.
―
Nippon Chemiphar Co., Ltd.
―
Taiko Pharmaceutical Co., Ltd.
―
Symbio Pharmaceuticals Limited
―
Ownership Overview
―
Insiders
―
Mutual Funds
― Other Institutional Investors
99.94% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---